We know the retail price of Qbrexza is $690/mnth. BOT have said Sofdra will be similiar, but with a little bit of a premium due to its superiority. BOT also advise this has been agreed to by all of the main players in the insurance world (I think they quoted 20 or so insurance companies).
We also know, that the actual costs for people that are insured is between $0-$50 cash out of pocket.
We know that more than 90% of the available market is covered by health insurance (i.e. most US citizens actually have commercial health insurance). It's hard to imagine actual cost of a script for the end-user being that influential overall - unless you're part of the 10% that unfortunately doesn't have insurance.
We know the retail price of Qbrexza is $690/mnth. BOT have said...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.010(3.64%) |
Mkt cap ! $448.9M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.3¢ | 28.0¢ | $1.520M | 5.359M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 28852 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 399879 | 4 |
View Market Depth
| Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
0.010 ( 2.89 %) |
||||
| Open | High | Low | Volume | ||
| 28.3¢ | 29.0¢ | 27.8¢ | 3154311 | ||
| Last updated 15.59pm 12/06/2024 ? | |||||
| BOT (ASX) Chart |